Association of BMP15 and GDF9 variants to premature ovarian insufficiency
- 111 Downloads
To identify genetic variation associated to premature ovarian insufficiency (POI).
A total of 74 women with POI (group POI), 45 women with increased FSH levels (group high FSH), and 88 controls (non-POI) were studied. Genotyping of BMP15:c.-9C>G (rs3810682), BMP15:c.328+905A>G (rs3897937), and BMP15:c.852C>T (rs17003221); and GDF9:c.134-694G>A (rs4705974), GDF9:c.-31-951G>A (rs11748063), GDF9:c.-152G>C (rs30177), and GDF9:g.1073C>T (rs803224) was performed by the TaqMan methodology. Chi-square and Fisher’s exact tests were performed to evaluate the distribution of genotypes, alleles, odds ratio, and the Hardy-Weinberg equilibrium of each variation. Haplotype analysis was performed for each gene considering the case and control groups. Bonferroni’s correction was applied to chi-square and Fisher’s exact test data, and p values < 0.007 for genotypes and alleles and < 0.006 for haplotypes were considered significant.
It was observed a statistically significant difference in genotype distribution of BMP15:c.852C>T between group POI and controls (p < 0.001). TT and TC genotypes were more frequently observed in group POI. Genotype distribution in case group POI, however, was not in the Hardy-Weinberg equilibrium, due to the increased number of heterozygotes in the sample. Concerning GDF9, no association was found among the studied genetic variants and POI or high FSH groups.
It is concluded from the present study that the genotypes CT and TT from BMP15:c.852C>T variation may be risk factors for the development of POI.
KeywordsPremature ovarian insufficiency BMP15 GDF9 Infertility Gene variants
Compliance with ethical standards
The research project was approved by the FMABC’s Ethics Committee and all patients read and signed the informed consent form.
- 1.Silva AA, Arent A, Petracco A, Mancebo AC, Bastos AM, Fraga AM, et al. Tratado de Reprodução Assistida. 1ª. Ed. São Paulo: Abril 2010.Google Scholar
- 9.Kovanci E, Simpson JL, Amato P, Rohozinski J, Heard MJ, Bishop CE, et al. Oocyte specific G protein coupled receptor-3 (GPR3) gene perturbations are not commonly involved in premature ovarian failure. Fertil Steril. Published online October 20, 2007.Google Scholar
- 12.Kedem A, Fisch B, Garor R, Ben-Zaken A, Gizunterman T, Felz C, et al. Growth differentiating factor 9 (GDF9) and bone morphogenetic protein 15 both activate development of human primordial follicles in vitro, with seemingly more beneficial effects of GDF9. J Clin Endocrinol Metab. 2011;96:1246–54.CrossRefGoogle Scholar
- 32.Duarte CW, Vaughan LK, Beasley TM, Tiwari HK. Multifactorial Inheritance and Complex Diseases. Emery and Rimoin’s principles and practice of medical genetics, 6th edn. 2013; chapter 12: 1–15. ISBN: 978–0–12-383834-6.Google Scholar